Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion type Assertion NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_head.
- NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion description "[In contrast, the frequency and the penetrance of SHANK3 mutations in individuals with ASD and intellectual disability-more than 1 in 50-warrant its consideration for mutation screening in clinical practice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_provenance.
- NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion evidence source_evidence_literature NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_provenance.
- NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion SIO_000772 25188300 NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_provenance.
- NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion wasDerivedFrom befree-2016 NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_provenance.
- NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_assertion wasGeneratedBy ECO_0000203 NP1216755.RABZPFl--E0gt7pm7tycrktak4MxTgFZrOIdrFTM17WSI130_provenance.